678 related articles for article (PubMed ID: 24481311)
1. The role of ligand efficiency metrics in drug discovery.
Hopkins AL; Keserü GM; Leeson PD; Rees DC; Reynolds CH
Nat Rev Drug Discov; 2014 Feb; 13(2):105-21. PubMed ID: 24481311
[TBL] [Abstract][Full Text] [Related]
2. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA
Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
[TBL] [Abstract][Full Text] [Related]
3. Applying thermodynamic profiling in lead finding and optimization.
Klebe G
Nat Rev Drug Discov; 2015 Feb; 14(2):95-110. PubMed ID: 25614222
[TBL] [Abstract][Full Text] [Related]
4. [Ligand efficiency and lead optimization].
Guo ZR
Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231
[TBL] [Abstract][Full Text] [Related]
5. An Application of Fit Quality to Screen MDM2/p53 Protein-Protein Interaction Inhibitors.
Xue X; Bao G; Zhang HQ; Zhao NY; Sun Y; Zhang Y; Wang XL
Molecules; 2018 Dec; 23(12):. PubMed ID: 30513790
[No Abstract] [Full Text] [Related]
6. Expanding the medicinally relevant chemical space with compound libraries.
López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the binding efficiencies of drugs and their leads in successful drug discovery programs.
Perola E
J Med Chem; 2010 Apr; 53(7):2986-97. PubMed ID: 20235539
[TBL] [Abstract][Full Text] [Related]
8. What is the future for fragment-based drug discovery?
Keserű GM; Hann MM
Future Med Chem; 2017 Sep; 9(13):1457-1460. PubMed ID: 28795595
[No Abstract] [Full Text] [Related]
9. Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.
Meanwell NA
Chem Res Toxicol; 2016 Apr; 29(4):564-616. PubMed ID: 26974882
[TBL] [Abstract][Full Text] [Related]
10. Molecular inflation, attrition and the rule of five.
Leeson PD
Adv Drug Deliv Rev; 2016 Jun; 101():22-33. PubMed ID: 26836397
[TBL] [Abstract][Full Text] [Related]
11. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
Zuegg J; Cooper MA
Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
[TBL] [Abstract][Full Text] [Related]
12. How are fragments optimized? A retrospective analysis of 145 fragment optimizations.
Ferenczy GG; Keserű GM
J Med Chem; 2013 Mar; 56(6):2478-86. PubMed ID: 23437770
[TBL] [Abstract][Full Text] [Related]
13. Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.
Cavalluzzi MM; Mangiatordi GF; Nicolotti O; Lentini G
Expert Opin Drug Discov; 2017 Nov; 12(11):1087-1104. PubMed ID: 28814111
[TBL] [Abstract][Full Text] [Related]
14. A comparison of physiochemical property profiles of development and marketed oral drugs.
Wenlock MC; Austin RP; Barton P; Davis AM; Leeson PD
J Med Chem; 2003 Mar; 46(7):1250-6. PubMed ID: 12646035
[TBL] [Abstract][Full Text] [Related]
15. The many roles of molecular complexity in drug discovery.
Méndez-Lucio O; Medina-Franco JL
Drug Discov Today; 2017 Jan; 22(1):120-126. PubMed ID: 27575998
[TBL] [Abstract][Full Text] [Related]
16. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
[TBL] [Abstract][Full Text] [Related]
17. Alternative variables in drug discovery: promises and challenges.
Abad-Zapatero C; Champness EJ; Segall MD
Future Med Chem; 2014 Apr; 6(5):577-93. PubMed ID: 24649959
[TBL] [Abstract][Full Text] [Related]
18. Biophysical screening for the discovery of small-molecule ligands.
Ciulli A
Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
[TBL] [Abstract][Full Text] [Related]
19. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
Williams G; Ferenczy GG; Ulander J; Keserű GM
Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
[TBL] [Abstract][Full Text] [Related]
20. Assessing the lipophilicity of fragments and early hits.
Mortenson PN; Murray CW
J Comput Aided Mol Des; 2011 Jul; 25(7):663-7. PubMed ID: 21614595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
